Reasons to Consider Investing in BioCurex: Patented and proprietary RECAF technology. Licensing agreement with Abbott Laboratories, the world's largest diagnostics healthcare company Technology platform for diagnostics and therapeutics First mover advantage Renowned scientific team Experienced management Favorable regulatory environment and approval process Significant and growing markets with huge demand for the technology Tests easily implemented by physicians Opportunity to reduce human suffering and develop a profitable investment